In multiethnic populations, exposure to per- and polyfluoroalkyl substance (PFAS) mixtures may be associated with increased odds of type 2 diabetes (T2D).

Moderate-to-vigorous physical activity (MVPA) decreases from young adulthood into middle age, with accelerated declines seen within 2 years prior to a cardiovascular disease (CVD) event.

In patients with T2D, sodium-glucose cotransporter-2 inhibitors better decrease risk for incident peripheral artery disease compared with DPP4is.

The US Department of Health and Human Services, US Department of Agriculture, and US Food and Drug Administration are gathering data to create a uniform definition of ultra-processed foods.

The FDA has approved Skytrofa (lonapegsomatropin-tcgd) for the replacement of growth hormone in adults with GHD.

Hybrid closed-loop systems were associated with improved glycemic control and safety during prolonged daytime fasting in type 1 diabetes.

RET carriers with moderate-risk variants had lower penetrance rates of medullary thyroid cancer than suggested by clinical studies.